Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial EDITORIAL COMMENT

Cathalijne C. B. Post; Stephanie M. de Boer; Melanie E. Powell; Linda Mileshkin; Dionyssios Katsaros; Paul Bessette; Alexandra Leary; Petronella B. Ottevanger; Mary McCormack; Pearly Khaw; Romerai D'Amico; Anthony Fyles; Cyrus Chargari; Henry C. Kitchener; Viet Do; Andrea Lissoni; Diane Procencher; Catherine Genestrie; Hans W. Nijman; Karen Whitmarsh; Ina M. Jurgenliemk-Schulz; Amanda Feeney; Ludy C. H. W. Lutgens; Jeanette Bouma; Alicia Leon-Castillo; Remi A. Nout; Hein Putter; Tjalling Bosse; Carien L. Creutzberg

doi:10.1097/OGX.0000000000001475

Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial EDITORIAL COMMENT

Cathalijne C. B. Post^*
, Stephanie M. de Boer
, Melanie E. Powell
, Linda Mileshkin
, Dionyssios Katsaros
, Paul Bessette
, Alexandra Leary
, Petronella B. Ottevanger
, Mary McCormack
, Pearly Khaw
, Romerai D'Amico
, Anthony Fyles
, Cyrus Chargari
, Henry C. Kitchener
, Viet Do
, Andrea Lissoni
, Diane Procencher
, Catherine Genestrie
, Hans W. Nijman
, Karen Whitmarsh

Ina M. Jurgenliemk-Schulz, Amanda Feeney, Ludy C. H. W. Lutgens, Jeanette Bouma, Alicia Leon-Castillo, Remi A. Nout, Hein Putter, Tjalling Bosse, Carien L. Creutzberg

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	757-759
Number of pages	3
Journal	Obstetrical & Gynecological Survey
Volume	80
Issue number	12
DOIs	https://doi.org/10.1097/OGX.0000000000001475
Publication status	Published - 1 Dec 2025

Access to Document

10.1097/OGX.0000000000001475

Cite this

Post, C. C. B., de Boer, S. M., Powell, M. E., Mileshkin, L., Katsaros, D., Bessette, P., Leary, A., Ottevanger, P. B., McCormack, M., Khaw, P., D'Amico, R., Fyles, A., Chargari, C., Kitchener, H. C., Do, V., Lissoni, A., Procencher, D., Genestrie, C., Nijman, H. W., ... Creutzberg, C. L. (2025). Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial EDITORIAL COMMENT. Obstetrical & Gynecological Survey, 80(12), 757-759. https://doi.org/10.1097/OGX.0000000000001475

Post, Cathalijne C. B. ; de Boer, Stephanie M. ; Powell, Melanie E. et al. / Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3) : 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial EDITORIAL COMMENT. In: Obstetrical & Gynecological Survey. 2025 ; Vol. 80, No. 12. pp. 757-759.

@article{2a03939ea8a14d0f9a9c982665eeb336,

title = "Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial EDITORIAL COMMENT",

author = "Post, \{Cathalijne C. B.\} and \{de Boer\}, \{Stephanie M.\} and Powell, \{Melanie E.\} and Linda Mileshkin and Dionyssios Katsaros and Paul Bessette and Alexandra Leary and Ottevanger, \{Petronella B.\} and Mary McCormack and Pearly Khaw and Romerai D'Amico and Anthony Fyles and Cyrus Chargari and Kitchener, \{Henry C.\} and Viet Do and Andrea Lissoni and Diane Procencher and Catherine Genestrie and Nijman, \{Hans W.\} and Karen Whitmarsh and Jurgenliemk-Schulz, \{Ina M.\} and Amanda Feeney and Lutgens, \{Ludy C. H. W.\} and Jeanette Bouma and Alicia Leon-Castillo and Nout, \{Remi A.\} and Hein Putter and Tjalling Bosse and Creutzberg, \{Carien L.\}",

year = "2025",

month = dec,

day = "1",

doi = "10.1097/OGX.0000000000001475",

language = "English",

volume = "80",

pages = "757--759",

journal = "Obstetrical \& Gynecological Survey",

issn = "0029-7828",

publisher = "Lippincott Williams \& Wilkins",

number = "12",

}

Post, CCB, de Boer, SM, Powell, ME, Mileshkin, L, Katsaros, D, Bessette, P, Leary, A, Ottevanger, PB, McCormack, M, Khaw, P, D'Amico, R, Fyles, A, Chargari, C, Kitchener, HC, Do, V, Lissoni, A, Procencher, D, Genestrie, C, Nijman, HW, Whitmarsh, K, Jurgenliemk-Schulz, IM, Feeney, A, Lutgens, LCHW, Bouma, J, Leon-Castillo, A, Nout, RA, Putter, H, Bosse, T & Creutzberg, CL 2025, 'Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial EDITORIAL COMMENT', Obstetrical & Gynecological Survey, vol. 80, no. 12, pp. 757-759. https://doi.org/10.1097/OGX.0000000000001475

Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial EDITORIAL COMMENT. / Post, Cathalijne C. B.; de Boer, Stephanie M.; Powell, Melanie E. et al.
In: Obstetrical & Gynecological Survey, Vol. 80, No. 12, 01.12.2025, p. 757-759.

Research output: Contribution to journal › Editorial › Academic › peer-review

TY - JOUR

T1 - Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3)

T2 - 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial EDITORIAL COMMENT

AU - Post, Cathalijne C. B.

AU - de Boer, Stephanie M.

AU - Powell, Melanie E.

AU - Mileshkin, Linda

AU - Katsaros, Dionyssios

AU - Bessette, Paul

AU - Leary, Alexandra

AU - Ottevanger, Petronella B.

AU - McCormack, Mary

AU - Khaw, Pearly

AU - D'Amico, Romerai

AU - Fyles, Anthony

AU - Chargari, Cyrus

AU - Kitchener, Henry C.

AU - Do, Viet

AU - Lissoni, Andrea

AU - Procencher, Diane

AU - Genestrie, Catherine

AU - Nijman, Hans W.

AU - Whitmarsh, Karen

AU - Jurgenliemk-Schulz, Ina M.

AU - Feeney, Amanda

AU - Lutgens, Ludy C. H. W.

AU - Bouma, Jeanette

AU - Leon-Castillo, Alicia

AU - Nout, Remi A.

AU - Putter, Hein

AU - Bosse, Tjalling

AU - Creutzberg, Carien L.

PY - 2025/12/1

Y1 - 2025/12/1

U2 - 10.1097/OGX.0000000000001475

DO - 10.1097/OGX.0000000000001475

M3 - Editorial

SN - 0029-7828

VL - 80

SP - 757

EP - 759

JO - Obstetrical & Gynecological Survey

JF - Obstetrical & Gynecological Survey

IS - 12

ER -

Post CCB, de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P et al. Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial EDITORIAL COMMENT. Obstetrical & Gynecological Survey. 2025 Dec 1;80(12):757-759. doi: 10.1097/OGX.0000000000001475